Literature DB >> 15582003

Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.

M Leunen1, M Breugelmans, Ph De Sutter, C Bourgain, J J Amy.   

Abstract

BACKGROUND: Low-grade endometrial stromal sarcoma is an indolent steroid responsive tumor. Successful hormonal treatment, most commonly with megestrol acetate, has been reported. CASE: A 76-year-old woman underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy 25 years earlier allegedly for a benign condition. She presented to us with postrenal kidney failure and a huge pelvic mass compressing both ureters. After transvaginal trough-cut biopsy of the mass, the diagnosis of low-grade endometrial stromal sarcoma with a high expression of alpha-estrogen receptor was made. The patient was treated with letrozole only with a spectacular response.
CONCLUSION: To the best of our knowledge, this is the first case for which letrozole was used on long-term basis as first-line hormonal treatment for a recurrent low-grade stromal sarcoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582003     DOI: 10.1016/j.ygyno.2004.07.063

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  18 in total

1.  Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.

Authors:  Keiko Shoji; Katsutoshi Oda; Shunsuke Nakagawa; Kei Kawana; Toshiharu Yasugi; Yuji Ikeda; Yutaka Takazawa; Shiro Kozuma; Yuji Taketani
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

2.  Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetate.

Authors:  Kentaro Nakayama; Masako Ishikawa; Yutaka Nagai; Nobuo Yaegashi; Yoichi Aoki; Khoji Miyazaki
Journal:  Int J Clin Oncol       Date:  2010-03-10       Impact factor: 3.402

3.  Long-term treatment of residual or recurrent low-grade endometrial stromal sarcoma with aromatase inhibitors: A report of two cases and a review of the literature.

Authors:  Hyewon Ryu; Yoon-Seok Choi; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim; Hyo Jin Lee
Journal:  Oncol Lett       Date:  2015-09-03       Impact factor: 2.967

4.  A case of multiple metastatic low-grade endometrial stromal sarcoma arising from an ovarian endometriotic lesion.

Authors:  Joo Yeon Kim; Seong Yeon Hong; Hyun Jung Sung; Hoon Kyu Oh; Suk Bong Koh
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

5.  Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist.

Authors:  Nefertiti Chianti Dupont; Philip John Disaia
Journal:  Sarcoma       Date:  2010-06-10

6.  Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.

Authors:  Jeong-Yeol Park; Min-Hyun Baek; Yangsoon Park; Young-Tak Kim; Joo-Hyun Nam
Journal:  Virchows Arch       Date:  2018-06-04       Impact factor: 4.064

Review 7.  Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques.

Authors:  Patricia Baker; Esther Oliva
Journal:  J Clin Pathol       Date:  2007-03       Impact factor: 3.411

Review 8.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

9.  Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors.

Authors:  Carmen Balañá; Enrique de Álava; Ruth Sardinha; Teresa Hernández; Susana Fraile; Francesc Tresserra; August Vidal; Maria Carmén Gómez; Aurora Astudillo; Nieves Hernández; Javier Saenz de Santamaría; Jaume Ordi; Luis Gonçalves; Rafael Ramos
Journal:  Clin Sarcoma Res       Date:  2013-03-07

10.  A case of endometrial stromal sarcoma with synchronous bilateral adenocarcinoma of ovary.

Authors:  Olga Caramelo; Carol Marinho; Teresa Rebelo; Natália Amaral; Fernando Mota; Fernanda Xavier da Cunha; Isabel Torgal
Journal:  Case Rep Obstet Gynecol       Date:  2012-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.